Tonix Pharmaceuticals (TNXP) Reports Q2 Loss of $0.50/Share
Tonix Pharmaceuticals (NASDAQ: TNXP) reported Q2 EPS of ($0.50), versus ($0.73) reported last year.
For earnings history and earnings-related data on Tonix Pharmaceuticals (TNXP) click here.
